Rapid lateral flow immunoassay (LFIA) for simultaneous qualitative detection of SARS-CoV-2, influenza A and B, adenovirus, respiratory syncytial virus, and Streptococcus A antigens. Designed for point-of-care respiratory pathogen screening in clinical and self-testing settings.
Manufactured by
Nanjing, Jiangsu, China
Jiangsu Medomics Medical Technology Co., Ltd., founded in October 2017, is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. Medomics owns two R D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 2,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions. At the very beginning of COVID-19 on early 2020, Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help against SARS-Cov-2. At present, Medomics s series products of SARS-Cov-2 detection have been developed according to ISO 13485 Quality System and European CE Certification.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Reagen Inc.
United States · 3 relevant products
Hangzhou AllTest Biotech Co.,Ltd
China · 8 relevant products
Hangzhou Fanttest Biotech Co., Ltd.
China · 4 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 3 relevant products
Biopanda Reagents
United Kingdom · 6 relevant products
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 1 relevant product
Goldsite Diagnostics Inc.
China · 2 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
Joinstar Biomedical Technology Co., Ltd.
China · 1 relevant product
ZET MEDİKAL TEKSTİL DIŞ TİC.LTD.ŞTİ.
Türkiye · 3 relevant products
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 110 closest product alternatives
Reagen Inc. · United States
A rapid antigen detection test kit for the simultaneous detection of SARS-CoV-2, respiratory syncytial virus (RSV), adenovirus (ADV), influenza A, and influenza B antigens. The kit is designed for use in human diagnostic testing to identify active viral infections.
Hangzhou AllTest Biotech Co.,Ltd · China
A multiplex rapid antigen test for simultaneous detection of SARS-CoV-2, Influenza A+B, and respiratory syncytial virus. This test provides comprehensive assessment for major respiratory viral infections.
Hangzhou Fanttest Biotech Co., Ltd. · China
A comprehensive rapid antigen test kit that detects COVID-19, RSV, Adenovirus, Influenza A, and Influenza B simultaneously. This multiplex test provides rapid diagnosis of five common respiratory pathogens in one test.
Hangzhou AllTest Biotech Co.,Ltd · China
A multiplex rapid diagnostic test that detects antigens for SARS-CoV-2, Influenza A+B, RSV, and Adenovirus in a single test.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
Biopanda Reagents · United Kingdom
A qualitative lateral flow immunochromatographic assay for detection of SARS-CoV-2, Influenza A+B, Respiratory Syncytial Virus (RSV), Adenovirus, and M. pneumoniae antigens in nasopharyngeal swab samples. This multiplex test assists in the diagnosis of multiple respiratory infections in conjunction with other diagnostic methods.
Hangzhou AllTest Biotech Co.,Ltd · China
A rapid diagnostic test that detects SARS-CoV-2 and Influenza A+B antigens using a nasal swab sample. This self-testing kit is designed for point-of-care use.
Hangzhou AllTest Biotech Co.,Ltd · China
A rapid diagnostic test that simultaneously detects SARS-CoV-2 and Influenza A+B antigens using a swab sample for point-of-care diagnosis.
Shenzhen Kingfocus Biomedical Engineering Co., Ltd. · China
Rapid antigen self-test kit for simultaneous detection of SARS-CoV-2, Influenza A and B, and RSV from respiratory or blood specimens. Designed for point-of-care testing with simplified workflow enabling quick identification of multiple respiratory pathogens in clinical and home settings.
Goldsite Diagnostics Inc. · China
Multiplex antigen test simultaneously detecting SARS-CoV-2, Influenza A/B, and RSV from a single patient sample. Enables rapid point-of-care diagnosis of common respiratory pathogens for clinical and emergency settings.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
Joinstar Biomedical Technology Co., Ltd. · China
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products